Product Reports Resources Pricing Login Book a demo
Tal Zaks
Person profile

Tal Zaks

LinkedIn
4 schools
Education

Currently

Active roles, board seats and partnerships.

Curevo Vaccine
Non Executive Director · 2025 – present
→
Exsilio Therapeutics
CEO · 2024 – present
→
Minervax
Non Executive Director · 2023 – present
→
Convergent Therapeutics
Non Executive Director · 2023 – present
→
iECURE, Inc.
Non Executive Director · 2022 – present
→
Teva
Non Executive Director · 2021 – present
→
OrbiMed
Partner · Venture Partner · 2021 – present
private_equity
→
University of Pennsylvania
Adjunct Associate Professor · 2004 – present
→

Work history

Past roles by Dealroom records.

PIC Therapeutics
Non Executive Director · 2022 – 2025
→
Adaptimmune
Non Executive Director · 2016 – 2023
→
Moderna Therapeutics
CMO · 2015 – 2021
→
Sanofi Aventis
VP · 2010 – 2015
→
Cephalon
VP · 2008 – 2010
→
Technology Transfer Center
Postdoctoral Fellow · 1996 – 1999
→

Education

PhD · 2021 – present
1986 – 1994
PhD · 1992 – 2000
2002 – 2004
← All people